Antengene

IPO

Public · Shanghai, China · Founded 2017 · $238.0M raised

Headquarters
Shanghai
Employees
201–500
Founded
2017
Business Model
B2B
Total Funding
$238.0M
Last Round
$97.0M Series CJul 2020
Rounds
3
Type
Public

About

Antengene Corporation Limited (SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class and best-in-class therapeutics for diseases with significant unmet medical needs. Its pipeline spans from preclinical to commercial stages, including ADCs, bispecific antibodies, and T cell engager programs developed on the proprietary AnTenGager® platform. Lead commercial asset XPOVIO® (selinexor) is approved in 10 Asia Pacific markets.

Summary

Antengene is a Biotech company based in Shanghai, China, founded in 2017. It has raised $238.0M in total across 3 rounds, most recently a $97.0M Series C round in Jul 2020. Investors include Fidelity Management, Boyu Capital and FountainVest Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPONov 2020
$335.0M

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Antengene on Indexed.vc
<a href="https://indexed.vc/companies/antengene"><img src="https://indexed.vc/api/badge/company/antengene" alt="Antengene on Indexed.vc" width="260" height="76" /></a>